Status: current, Primitive. Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4551295019 | Umbralisib (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 4551296018 | Umbralisib | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Umbralisib | Is a | Antineoplastic agent | true | Inferred relationship | Some | ||
| Umbralisib | Is a | Heterocyclic compound | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Umbralisib only product | Has active ingredient | True | Umbralisib | Inferred relationship | Some | 1 |
| Umbralisib-containing product | Has active ingredient | True | Umbralisib | Inferred relationship | Some | 1 |
| Umbralisib tosylate | Is modification of | True | Umbralisib | Inferred relationship | Some | |
| Umbralisib-containing product in oral dose form | Has active ingredient | True | Umbralisib | Inferred relationship | Some | 1 |
| Umbralisib only product in oral dose form | Has active ingredient | True | Umbralisib | Inferred relationship | Some | 1 |
| Umbralisib (as umbralisib tosylate) 200 mg oral tablet | Has BoSS | True | Umbralisib | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR